Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease.
Amal A MohamedDina M Abo-ElmattyOmnia EzzatNoha M MesbahNada S AliAliaa Sayed Abd El FatahEman AlsayedMahmoud Hamada ImamAlshymaa A HassnineSherief M Abd-ElsalamAhmed AbdelghaniMohamed Badr HassanShaimaa A FattahPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2022)
The circulating pro-neurotensin might be used as a novel biomarker for diagnosis of patients with NAFLD, wherefore the integration of a circulating mi-RNA-122 and serum pro-neurotensin could be beneficial to diagnose NAFLD cases. Large-scale studies are needed to investigate the possible role of mi-RNA-122 and pro-neurotensin in the development, progression, and prognosis of NAFLD and NASH.